OSIR.org.in - Obama Pick: Buy Osiris Therapeutics (OSIR) - Bloggingstocks.com
Looking for stocks that should benefit now that Senator Obama is officially President-Elect Obama? Many investors believe that liberals negatively impact stock markets in general and that the only companies to benefit from a liberal adminstration are
Source: www.bloggingstocks.com
NuVasive raises revenue outlook for 2008 - Forbes
Medical device maker NuVasive Inc. maintained its 2008 profit forecast, but predicted increased revenue that was above Wall Street expectations. NuVasive (nasdaq: NUVA - news - people ) now expects revenue of $245 million to $247 million, up from its
Source: www.forbes.com
UPDATE 1-Genzyme, Osiris to develop stem cell products - Reuters
Nov 4 (Reuters) - Genzyme Corp (GENZ.O: Quote , Profile , Research , Stock Buzz ) said it would co-develop and market two adult stem cell products of Osiris Therapeutics (OSIR.O: Quote , Profile , Research , Stock Buzz ) that are being tested for
Source: www.reuters.com
Amylin, Orient-Express, PFG, Sun: U.S. Equity Movers (Correct) - Bloomberg
Nov. 4 (Bloomberg) — The following companies are having unusual price changes in U.S. trading today. Stock symbols are in parentheses, and share prices are as of 12:15 p.m. in New York. Amylin Pharmaceuticals Inc. (AMLN US) retreated 21 percent to
Source: www.bloomberg.com
Refer to a friend - PR Inside
Rodman & Renshaw Annual Global Investment Conference - Osiris Therapeutics, Inc. (NASDAQ:OSIR), a leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and
Source: www.pr-inside.com